Thermo Fisher Deepens Its China Commitment With New Innovation Center
This article was originally published in PharmAsia News
Executive Summary
After nearly doubling its workforce in China within two years, laboratory service provider Thermo Fisher is accelerating its local presence with plans to add hundreds of engineers and to train thousands of local customers each year.
You may also be interested in...
Life Technologies Extends Thermo Fisher’s Reach Into Clinical Practice
Thermo Fisher’s $13.6 billion bid for Life Technologies is a blockbuster move within the instrumentation and consumables space, and also has implications for clinical practice. It’s another sign of the growing recognition that integrating clinical workflow is an important potential area for innovation and growth, along with the desire to move genomics tools into clinical use and the development of test content by nontraditional players in diagnostics.
Medtronic Launches New Facilities In Shanghai And Singapore; Thermo Fisher To Open Fifth China Plant
Medtronic Inc. raised its Asian profile last week with opening ceremonies for a regional headquarters building in Shanghai and a manufacturing plant in Singapore. The company plans to add 1,000 skilled staff to its China workforce in the next five years
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.